News
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson, marking the latest twist in an unusual run leading the FDA office overseeing vaccines and gene therapy.
Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration, a little more than a week after he had left ...
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for ...
Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA. He has our enthusiastic support. Prasad is ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
Rare disease and gene therapy stocks, battered in recent months by clinical and commercial setbacks, will likely benefit from the sudden departure this past week of Vinayak (Vinay) Prasad, MD, as ...
Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback